ArticleNatural products and bioprospecting2026
Metabolite diversification via halogen salts enhances biocontrol potential of marine-derived Trichoderma virens B211.
Article in Natural products and bioprospecting, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In the search for natural products with potent activity against plant diseases, we employed the one strain-many compounds (OSMAC) strategy to the marine-derived fungus Trichoderma virens B211 by supplementing cultures with halogen salts such as sodium bromide (NaBr). Both solid and liquid cultures grown under NaBr-supplemented conditions exhibited markedly darker pigmentation of B211, a diversified secondary metabolite profile, and enhanced antibacterial activity against Erwinia amylovora. Bioassay-guided fractionation of these extracts led to the isolation of fourteen compounds (1-14), including two new polycyclic aromatic terpenoids (1 and 5) belonging to the viridin family. In vitro antimicrobial assays demonstrated that viridin (3) and β-viridin (4), together with gliotoxin (8), displayed broad-spectrum activity against diverse plant pathogenic fungi and bacteria. Notably, viridin derivatives 1 and 2, which are structural isomers, exhibited distinct bioactivity profiles: compound 1 exhibited antifungal activity, whereas compound 2 showed antibacterial activity. Among the isolated metabolites, only gliotoxin (8) and bisdethiobis(methylthio)gliotoxin (9) exhibited direct antibacterial activity against E. amylovora. Furthermore, NaBr-induced crude extracts in which compounds 8 and 9 were the major constituents, as well as the purified compounds themselves, effectively suppressed fire blight symptoms. Collectively, these findings highlight the effectiveness of the OSMAC approach in expanding the chemical diversity of metabolites produced by T. virens B211 and enhancing its potential as a biocontrol agent for plant disease management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.